Clinical Trials Logo

Facial Wrinkles clinical trials

View clinical trials related to Facial Wrinkles.

Filter by:

NCT ID: NCT00888914 Completed - Facial Wrinkles Clinical Trials

Safety and Efficacy Study of RT001 to Treat Moderate to Severe Lateral Canthal Lines

Start date: November 2008
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of RT001 to treat moderate to severe lateral canthal lines in adults.

NCT ID: NCT00877279 Completed - Facial Wrinkles Clinical Trials

Multicenter Study of the Safety and Efficacy of Dermal Filler, Belotero® Soft

Start date: November 2007
Phase: Phase 3
Study type: Interventional

This study is to determine the safety and effectiveness of Belotero® Soft compared to active comparator in the correction of mild facial wrinkles, such as nasolabial folds.

NCT ID: NCT00876265 Completed - Facial Wrinkles Clinical Trials

Multicenter Study of the Safety and Effectiveness of Dermal Filler, Belotero®.

Start date: December 2006
Phase: Phase 3
Study type: Interventional

This was a study to find out how an investigational product, Belotero, compares to a second product in people with facial wrinkles, such as nasolabial folds. Nasolabial folds are wrinkles on the face that go from the outside of the nostrils to the edges of the mouth. Additionally, this study determined Belotero is safe and tolerable and corrects facial wrinkles, such as nasolabial folds.

NCT ID: NCT00734786 Withdrawn - Facial Wrinkles Clinical Trials

Efficacy and Safety of a Cutaneous Formulation of Gonyautoxin 2/3 (GTX 2/3) for the Treatment of Facial Wrinkles

Start date: August 2008
Phase: Phase 1/Phase 2
Study type: Interventional

The main objective of the trial is to determine whether the current topical formulation of GTX 2/3 reduces the wrinkling of the skin (crow's feet) after a single application Other evaluation criteria include: safety assessment and local tolerance, depth of facial wrinkles (video microscopy imaging).

NCT ID: NCT00417469 Completed - Facial Wrinkles Clinical Trials

A Study to Compare Subject Comfort During and After Injections With the Study Products and the Safety of the Non-FDA Approved Product for the Correction of Nasolabial Folds (NLFs)

Start date: January 2007
Phase: Phase 3
Study type: Interventional

The purpose of this research study is to compare subject comfort during and after injection with NADGL and Captique® Injectable Gel, in the nasolabial folds. Captique® is an FDA-approved product without lidocaine and is manufactured by Genzyme Biosurgery (Ridgefield, NJ). NADGL is a new product (not FDA approved) with lidocaine and is also manufactured by Genzyme Biosurgery. We do not know which of these treatments results in less pain during and after injection. The safety of NADGL is also being studied.

NCT ID: NCT00414544 Completed - Facial Wrinkles Clinical Trials

Evaluation of the Safety and Efficacy of CosmetaLifeā„¢ for the Correction of Nasolabial Folds

Start date: October 2006
Phase: Phase 2
Study type: Interventional

This is a randomized, double-blind pivotal study to evaluate the safety and effectiveness of CosmetaLife injectable dermal filler for the correction of wrinkles and folds, such as nasolabial folds (i.e., smile lines).

NCT ID: NCT00407914 Completed - Facial Wrinkles Clinical Trials

Safety and Effectiveness of Aquamid as Compared to Restylane for the Aesthetic Treatment of Nasolabial Folds

Start date: December 2006
Phase: N/A
Study type: Interventional

The purpose of this study is to compare the effectiveness of Aquamid and Restylane in aesthetically enhancing nasolabial folds 6 months after treatment and to evaluate the safety of Aquamid through 12 months after treatment. The study includes an extended follow up to 24 months.

NCT ID: NCT00293163 Completed - Facial Wrinkles Clinical Trials

A Post-Market Study to Evaluate Adverse Event Incidence Rates in Patients With Skin of Color Undergoing Correction of Nasolabial Folds With Hylaform, Hylaform Plus and Captique.

Start date: February 2006
Phase: Phase 4
Study type: Interventional

To assess the likelihood of keloid and scar formation, pigmentation disorders and hypersensitivity reactions in patients with skin of color undergoing correction of facial soft tissue contour deficiencies with Hylaform, Hylaform Plus or Captique.

NCT ID: NCT00288470 Completed - Facial Wrinkles Clinical Trials

A Double-blinded Evaluation of Safety and Efficacy of Hylaform and Hylaform Plus Compared to Zyplast.

Start date: June 2002
Phase: N/A
Study type: Interventional

A clinical study to investigate the safety and efficacy of Hylaform and Hylaform Plus for correction of facial wrinkles.